LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. LDL SUBFRACTIONAL ANALYSIS: A LABORATORY DIAGNOSTIC ASSAY IN PATIENTS WITH CAROTID AND CORONARY ATHEROSCLEROSIS

被引：0
|
作者：
Gavrilova, N. [1 ]
Metelskaya, V. [2 ]
Ozerova, I. [2 ]
Yarovaya, E. [3 ]
Boytsov, S. [1 ]
机构：
[1] Natl Res Ctr Prevent Med, Cardiol, Moscow, Russia
[2] Natl Res Ctr Prevent Med, Biochem, Moscow, Russia
[3] Natl Res Ctr Prevent Med, Biostat, Moscow, Russia
来源：
ATHEROSCLEROSIS | 2016年 / 252卷
关键词：
D O I：
10.1016/j.atherosclerosis.2016.07.571
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS16-0095
引用
收藏
页码：E101 / E101
页数：1
相关论文
共 37 条
  • [21] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. LIPOPROTEINS FROM CORD BLOOD OF SMALL BABY FOR GESTATIONAL AGE SHOWED ELEVATED TRIGLYCERIDE AND DIMINISHED APOA-I CONTENT WITH MORE PRO-ATHEROSCLEROTIC AND PROINFLAMMATORY ACTIVITY
    Kim, S. M.
    Kyung-Hyun, C.
    ATHEROSCLEROSIS, 2016, 252 : E101 - E102
  • [22] Plasma metabolism of apoB-containing lipoproteins in patients with hepatic lipase deficiency
    Ruel, IL
    Couture, P
    Cohn, JS
    Lamarche, B
    ATHEROSCLEROSIS, 2005, 180 (02) : 355 - 366
  • [23] Effect of sirolimus on the metabolism of ApoB100-containing lipoproteins in renal transplant patients
    Hoogeveen, RC
    Ballantyne, CM
    Pownall, HJ
    Opekun, AR
    Hachey, DL
    Jaffe, JS
    Oppermann, S
    Kahan, BD
    Morrisett, JD
    TRANSPLANTATION, 2001, 72 (07) : 1244 - 1250
  • [24] LIPOPROTEINS AND LIPID METABOLISM: APOB CONTAINING LIPOPROTEINS. 14C MIRISTIC ACID AND 3H CHOLESTEROL UPTAKE STUDIES IN AGING RABBIT AORTA AND HEART MUSCLE. THE IMPACT OF SERUM FACTORS FROM PATIENTS WITH LIPID METABOLIC DISORDERS
    Revnic, C. R.
    Pena, C.
    Revnic, F.
    Voinea, S.
    Paltineanu, B.
    ATHEROSCLEROSIS, 2016, 252 : E101 - E101
  • [25] ApoB lipoproteins containing ApoC3 are risk factors for recurrent coronary events in diabetic patients
    Lee, SJ
    Moye, L
    Sacks, FM
    DIABETES, 2001, 50 : A7 - A8
  • [26] LIPOPROTEINS AND LIPID METABOLISM: HDL. HDL AS A CRUCIAL INDICATOR OF AN EARLY CLINICAL MANIFESTATION OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Urazgildeeva, S.
    Muzalevskaya, M. V.
    Tregubov, A. V.
    Nekrasova, T. V.
    Gurevich, V. S.
    ATHEROSCLEROSIS, 2016, 252 : E113 - E113
  • [27] EFFECTS OF LOVASTATIN ON APOA-CONTAINING AND APOB-CONTAINING LIPOPROTEINS - FAMILIES IN A SUBPOPULATION OF PATIENTS PARTICIPATING IN THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS)
    ALAUPOVIC, P
    HODIS, HN
    KNIGHTGIBSON, C
    MACK, WJ
    LABREE, L
    CASHINHEMPHILL, L
    CORDER, CN
    KRAMSCH, DM
    BLANKENHORN, DH
    ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (12): : 1906 - 1914
  • [28] MORE AGGRESSIVE LDL-C AND NON-HDL-C TARGETS MUST BE ACHIEVED IN PATIENTS RECEIVING LIPID-LOWERING THERAPY TO NORMALIZE APOB-CONTAINING LIPOPROTEINS
    Betteridge, J.
    Guyton, J. R.
    Farnier, M.
    Leiter, L. A.
    Lin, J.
    Shah, A.
    Johnson-Levonas, A. O.
    Brudi, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 163 - 164
  • [29] PROTEIN-LIPID CONTENT OF HIGH-DENSITY LIPOPROTEINS IN PATIENTS WITH CORONARY ATHEROSCLEROSIS AND WITH DIFFERENT LEVELS OF ALPHA-LIPOPROTEIN CHOLESTEROL
    KURDANOV, KA
    POLESSKY, VA
    DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1980, 35 (43): : 1716 - 1719
  • [30] ANALYSIS OF RARE VARIANTS IN GENES RELATED TO ABERRATIONS OF LIPID METABOLISM IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
    Shakhtshneider, E. V.
    Ivanoshchuk, D.
    Fishman, V.
    Ragino, Y.
    Polonskaya, Y.
    Kashtanova, E.
    Chernyavsky, A.
    Voevoda, M. I.
    ATHEROSCLEROSIS, 2020, 315 : E230 - E230
1234